Home
EMBC
EMBC News

Latest Embecta Corp. (EMBC) News on May 10, 2025

Embecta Corp. (EMBC) Tops Q2 Earnings Estimates

Zacks

a day ago

Embecta Corp. (EMBC) Tops Q2 Earnings Estimates

3 Undervalued Small Caps With Insider Activity Across Global Markets

Simply Wall St.

a day ago

3 Undervalued Small Caps With Insider Activity Across Global Markets

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

GlobeNewswire

a day ago

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

Is Now An Opportune Moment To Examine Embecta Corp. (NASDAQ:EMBC)?

Simply Wall St.

a day ago

Is Now An Opportune Moment To Examine Embecta Corp. (NASDAQ:EMBC)?

embecta Announces Quarterly Cash Dividend

GlobeNewswire

a day ago

embecta Announces Quarterly Cash Dividend

Argus Research

3 days ago

EMBC: What does Argus have to say about EMBC?

Embecta to host Analyst and Investor Day on May 22, 2025

GlobeNewswire

12 days ago

Embecta to host Analyst and Investor Day on May 22, 2025

Argus Research

17 days ago

EMBC: Lowering target price to $12.00

Beyond the drug: Closing the knowledge gap for injectable diabetes meds

Pharma Voice

18 days ago

Beyond the drug: Closing the knowledge gap for injectable diabetes meds

embecta to Report Fiscal Second Quarter 2025 Financial Results

GlobeNewswire

19 days ago

embecta to Report Fiscal Second Quarter 2025 Financial Results

Argus Research

24 days ago

EMBC: Raising target price to $13.00

MT Newswires

a month ago

Mizuho Initiates Embecta at Neutral With $15 Price Target

Argus Research

a month ago

EMBC: Lowering target price to $12.00

Argus Research

a month ago

EMBC: What does Argus have to say about EMBC?

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

GlobeNewswire

a month ago

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

Undervalued Small Caps With Insider Action Across Regions In April 2025

Simply Wall St.

a month ago

Undervalued Small Caps With Insider Action Across Regions In April 2025

Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%?

Simply Wall St.

a month ago

Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%?

Argus Research

a month ago

EMBC: Lowering target price to $13.00

Argus Research

2 months ago

EMBC: Lowering target price to $13.00

Embecta Insider Ups Holding By 20% During Year

Simply Wall St.

2 months ago

Embecta Insider Ups Holding By 20% During Year

Argus Research

2 months ago

EMBC: Lowering target price to $14.00

Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

Insider Monkey

3 months ago

Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

Argus Research

3 months ago

EMBC: Lowering target price to $16.00

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

GlobeNewswire

3 months ago

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

GuruFocus.com

3 months ago

Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

MT Newswires

3 months ago

Embecta's Fiscal Q1 Adjusted Earnings Rise, Revenue Declines

Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Zacks

3 months ago

Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

GlobeNewswire

3 months ago

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

embecta Announces Quarterly Cash Dividend

GlobeNewswire

3 months ago

embecta Announces Quarterly Cash Dividend

Argus Research

3 months ago

EMBC: Lowering target price to $19.00

embecta to Report Fiscal First Quarter 2025 Financial Results

GlobeNewswire

4 months ago

embecta to Report Fiscal First Quarter 2025 Financial Results

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

Zacks

4 months ago

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Zacks

4 months ago

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Argus Research

4 months ago

EMBC: Rating increased to a HOLD

Argus Research

4 months ago

EMBC: What does Argus have to say about EMBC?

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

Zacks

4 months ago

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

3 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks

4 months ago

3 Stocks Trading Near 52-Week High With Room to Rise Further

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

Zacks

4 months ago

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

Zacks

5 months ago

Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

Argus Research

5 months ago

EMBC: What does Argus have to say about EMBC?

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

5 months ago

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

5 months ago

EMBC: What does Argus have to say about EMBC?

Argus Research

5 months ago

EMBC: What does Argus have to say about EMBC?

Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC)

Zacks

5 months ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC)

Embecta to cut 125 jobs after ending insulin patch pump

MedTech Dive

5 months ago

Embecta to cut 125 jobs after ending insulin patch pump

Argus Research

5 months ago

EMBC: Raising target price to $16.00

Best Value Stocks to Buy for December 2nd

Zacks

5 months ago

Best Value Stocks to Buy for December 2nd

Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?

Simply Wall St.

5 months ago

Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?

MT Newswires

5 months ago

BTIG Research Upgrades Embecta to Buy From Neutral, $26 Price Target

Embecta to discontinue insulin patch pump program, initiates restructuring plan

TipRanks

5 months ago

Embecta to discontinue insulin patch pump program, initiates restructuring plan

GuruFocus.com

5 months ago

Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Embecta Corp Earnings Call

Argus Research

5 months ago

EMBC: Raising target price to $15.00

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps

Benzinga

5 months ago

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps

Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates

Zacks

5 months ago

Embecta Corp. (EMBC) Tops Q4 Earnings and Revenue Estimates

MT Newswires

5 months ago

Embecta Fiscal Q4 Adjusted Earnings Decline, Revenue Increases; Fiscal 2025 Guidance Issued

MT Newswires

5 months ago

Embecta Discontinues Insulin Patch Pump Program, Initiates Organizational Restructuring Plan

Embecta discontinues insulin patch pump development

MedTech Dive

5 months ago

Embecta discontinues insulin patch pump development

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

GlobeNewswire

5 months ago

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

embecta Announces Quarterly Cash Dividend

GlobeNewswire

5 months ago

embecta Announces Quarterly Cash Dividend

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

6 months ago

Inside a $400 billion bet on the brain-computer interface revolution

Argus Research

6 months ago

EMBC: What does Argus have to say about EMBC?

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

6 months ago

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

6 months ago

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

GlobeNewswire

6 months ago

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

Argus Research

6 months ago

EMBC: What does Argus have to say about EMBC?

Argus Research

7 months ago

EMBC: What does Argus have to say about EMBC?

Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump

Zacks

8 months ago

Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump

MT Newswires

8 months ago

Sector Update: Health Care Stocks Retreat in Afternoon Trading

MT Newswires

8 months ago

Embecta Gets FDA Clearance for Disposable Insulin Patch Pump for Diabetes

Embecta gets FDA nod for insulin patch pump

MedTech Dive

8 months ago

Embecta gets FDA nod for insulin patch pump

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

GlobeNewswire

8 months ago

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

Argus Research

8 months ago

EMBC: What does Argus have to say about EMBC?

embecta to Participate in Investor Events

GlobeNewswire

9 months ago

embecta to Participate in Investor Events

Argus Research

9 months ago

EMBC: What does Argus have to say about EMBC?

Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Simply Wall St.

9 months ago

Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

Simply Wall St.

9 months ago

Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15

Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average

Zacks

9 months ago

Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average

Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average

Zacks

9 months ago

Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average

Embecta Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Embecta Third Quarter 2024 Earnings: Beats Expectations

MT Newswires

9 months ago

Embecta Shares Rise After Fiscal Q3 Beat; Fiscal 2024 EPS Guidance Raised

Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates

Zacks

9 months ago

Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire

9 months ago

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

embecta Announces Quarterly Cash Dividend

GlobeNewswire

9 months ago

embecta Announces Quarterly Cash Dividend

Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline

Zacks

9 months ago

Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline

Is There An Opportunity With Embecta Corp.'s (NASDAQ:EMBC) 35% Undervaluation?

Simply Wall St.

9 months ago

Is There An Opportunity With Embecta Corp.'s (NASDAQ:EMBC) 35% Undervaluation?

Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock?

Zacks

9 months ago

Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock?

MT Newswires

9 months ago

Genpact Says Providing Support to Embecta in Post Spin-Off Transition

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

PR Newswire

9 months ago

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength?

Zacks

10 months ago

Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength?

Argus Research

10 months ago

EMBC: Raising target price to $17.00

Diabetes device firm Embecta considers sale: Financial Times

MedTech Dive

10 months ago

Diabetes device firm Embecta considers sale: Financial Times

embecta to Report Fiscal Third Quarter 2024 Financial Results

GlobeNewswire

10 months ago

embecta to Report Fiscal Third Quarter 2024 Financial Results

Argus Research

10 months ago

EMBC: Raising target price to $14.00

Argus Research

10 months ago

EMBC: What does Argus have to say about EMBC?

Embecta touts its insulin patch pump at ADA

MedTech Dive

10 months ago

Embecta touts its insulin patch pump at ADA

embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

GlobeNewswire

a year ago

embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

Why Embecta Corp. (NASDAQ:EMBC) Could Be Worth Watching

Simply Wall St.

a year ago

Why Embecta Corp. (NASDAQ:EMBC) Could Be Worth Watching

Best Value Stocks to Buy for May 15th

Zacks

a year ago

Best Value Stocks to Buy for May 15th

Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript

Insider Monkey

a year ago

Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript

Share on Social Networks: